Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?

Most prostate cancer-related deaths occur in patients with castration-resistant prostate cancer (CRPC). Until recently, only therapy with docetaxel and prednisone has been shown to prolong survival in men with metastatic CRPC. With the United States Food and Drug Administration (US FDA) approvals of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitting, Rhonda L., Armstrong, Andrew J., George, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Consise Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210626/
https://www.ncbi.nlm.nih.gov/pubmed/22084621
http://dx.doi.org/10.4137/CMO.S5977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210626/
https://www.ncbi.nlm.nih.gov/pubmed/22084621
http://dx.doi.org/10.4137/CMO.S5977

Ejemplares similares